Clinical trial

Chemotherapy Combined With Radiation Therapy in Treating Patients With…

NCT00059761 · Radiation Therapy Oncology Group, Other · Completed

Key facts

NCT number NCT00059761
Title Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Official title Phase I Study of Irinotecan and Cisplatin in Combination With Twice Daily Thoracic Radiotherapy (45 Gy) or Once Daily Thoracic Radiotherapy (70 Gy) for Patients With Limited Stage Small Cell Lung Cancer
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Radiation
Interventions cisplatin, irinotecan hydrochloride, radiation therapy
Enrollment 36
Start date Mar 1, 2003
Primary completion Mar 1, 2009
Completion Nov 1, 2013
First posted May 7, 2003
Last update posted Nov 17, 2015
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies